Laterveer L, van Damme J, Willemze R, Fibbe W E
Laboratory of Experimental Hematology, University Medical Center Leiden, The Netherlands.
Exp Hematol. 1993 Dec;21(13):1621-7.
Interleukin-6 (IL-6) is a pleiotropic cytokine that enhances the maturation of megakaryocytes. In mice, in vivo treatment with IL-6 results in elevated platelet counts both in untreated animals and after myelosuppressive therapy. In this study, we assessed the effect of continuous infusion of IL-6 in sublethally irradiated (7 Gy) mice on peripheral blood cell counts and progenitor cells in bone marrow and spleen. Female Swiss mice were treated by continuous infusion with 1 or 10 micrograms IL-6 per day for 7 or 14 days. Continuous infusion of IL-6 for 7 days resulted in elevated levels of circulating IL-6 (mean: 1872 pg/mL vs. 100 pg/mL for phosphate-buffered saline [PBS]-treated controls) and in an accelerated reconstitution of platelets starting at day 12 after irradiation. In IL-6-treated animals, the 50% pretreatment platelet count was reached on day 15 vs. day 21 for irradiated controls receiving no IL-6. Treatment with IL-6 for 14 days resulted in a further increase in platelet counts, exceeding the pretreatment counts. The number of colony-forming units-megakaryocyte (CFU-Mk) was significantly elevated from day 6 to 18 in the spleen but not in bone marrow. To assess the contribution of extramedullary megakaryocytopoiesis in the spleen to IL-6-induced platelet recovery, IL-6 was also administered to splenectomized mice. The stimulatory effect of IL-6 on platelet recovery was preserved in these animals, indicating that megakaryocytopoiesis in the spleen did not contribute to the accelerated recovery of platelets. The neutrophil counts were elevated during IL-6 treatment and became similar to controls after cessation of therapy, whereas the numbers of colony-forming units-granulocyte/macrophage (CFU-GM) in the bone marrow were elevated from day 9 to 24 in all animals treated with 10 micrograms IL-6 per day. In conclusion, continuous infusion of IL-6 stimulates platelet recovery after irradiation without increasing the number of CFU-Mk and conversely stimulates the proliferation of myeloid progenitor cells without an effect on neutrophil reconstitution.
白细胞介素-6(IL-6)是一种多效性细胞因子,可促进巨核细胞成熟。在小鼠中,对未经处理的动物以及骨髓抑制治疗后的动物进行IL-6体内治疗,都会导致血小板计数升高。在本研究中,我们评估了对亚致死剂量照射(7 Gy)的小鼠持续输注IL-6对其外周血细胞计数以及骨髓和脾脏中祖细胞的影响。对雌性瑞士小鼠每天持续输注1或10微克IL-6,持续7天或14天。持续输注IL-6 7天导致循环IL-6水平升高(平均值:1872 pg/mL,而磷酸盐缓冲盐水[PBS]处理的对照为100 pg/mL),并在照射后第12天开始加速血小板重建。在接受IL-6治疗的动物中,在第15天达到预处理血小板计数的50%,而未接受IL-6的照射对照在第21天达到。用IL-6治疗14天导致血小板计数进一步增加,超过预处理计数。从第6天到第18天,脾脏中巨核细胞集落形成单位(CFU-Mk)的数量显著升高,但骨髓中未升高。为了评估脾脏中髓外巨核细胞生成对IL-6诱导的血小板恢复的贡献,也对脾切除的小鼠给予IL-6。在这些动物中,IL-6对血小板恢复的刺激作用得以保留,表明脾脏中的巨核细胞生成对血小板的加速恢复没有贡献。在IL-6治疗期间中性粒细胞计数升高,治疗停止后与对照相似,而每天接受10微克IL-6治疗的所有动物骨髓中粒细胞/巨噬细胞集落形成单位(CFU-GM)的数量从第9天到第24天升高。总之,持续输注IL-6可刺激照射后血小板恢复,而不增加CFU-Mk数量,相反,刺激髓系祖细胞增殖,而对中性粒细胞重建无影响。